CRS

CRS Change in Working Capital

-$11.60MTTM · USD

Period ending:

CRS FY Change in Working CapitalUSD
CRS FY Change in Working Capital1990-06-30: -$29.20M1991-06-30: -$8.10M1992-06-30: $20.40M1993-06-30: $42.40M1994-06-30: $15.00M1995-06-30: -$29.40M1996-06-30: -$36.90M1997-06-30: -$13.40M1998-06-30: -$31.50M1999-06-30: $4.50M2000-06-30: -$30.90M2001-06-30: $7.80M2002-06-30: $85.50M2003-06-30: $32.40M2004-06-30: -$21.70M2005-06-30: -$43.50M2006-06-30: -$22.60M2007-06-30: -$12.70M2008-06-30: $6.20M2009-06-30: $6.20M2010-06-30: -$8.40M2011-06-30: -$130.60M2012-06-30: -$153.40M2013-06-30: -$155.60M2014-06-30: -$66.20M2015-06-30: -$30.40M2016-06-30: $10.90M2017-06-30: -$143.20M2018-06-30: -$69.10M2019-06-30: -$91.60M2020-06-30: -$41.70M2021-06-30: $220.70M2022-06-30: -$80.00M2023-06-30: -$211.10M2024-06-30: -$163.20M2025-06-30: -$109.50M2026-06-30: -$11.60M$220.70M-$211.10M
1990-06-302026-06-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CRS change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 37 observations from Jun 30, 1990 to Jun 30, 2026.

Carpenter Technology Corporation Common Stock Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
-11,600,000
-109,500,000
-163,200,000
-211,100,000
-80,000,000
220,700,000
-41,700,000
-91,600,000
-69,100,000
-143,200,000
10,900,000
-30,400,000
-66,200,000
-155,600,000
-153,400,000
-130,600,000
-8,400,000
6,200,000
6,200,000
-12,700,000
-22,600,000
-43,500,000
-21,700,000
32,400,000
85,500,000
7,800,000
-30,900,000
4,500,000
-31,500,000
-13,400,000
-36,900,000
-29,400,000
15,000,000
42,400,000
20,400,000
-8,100,000
-29,200,000

Compare change in working capital

All CRS financial metrics · CRS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.